INDIANA UNIVERSITY SCHOOL OF MEDICINE SCIENTIST RECEIVES RESEARCH GRANT FROM THE ALZHEIMER’S ASSOCIATION
The Alzheimer’s Association has awarded more than $159,000 to Claudia Mera Reina MD, M.Sc, PhD, postdoctoral research associate for the Stark Neuroscience Research Institute at Indiana University School of Medicine.
This research aims to better understand the complex relationship between traumatic brain injury (TBI) and Alzheimer’s disease (AD), two severe neurological disorders. TBI can trigger abnormal microglial activity, which may accelerate the development of AD-like pathology. This study focuses on Hexokinase 2 (HK2), a key glycolytic enzyme that drives inflammation in microglia. By investigating the role of HK2 in a mouse model of head injury, this research will help clarify how microglial metabolism contributes to the progression from TBI to AD, potentially uncovering mechanisms that inform future therapeutic approaches.
This grant award comes through the Association’s 2025 International Research Grant Program.
The Alzheimer’s Association funds more Alzheimer’s and dementia research than any other nonprofit globally to accelerate the field towards solutions for the global Alzheimer’s crisis. The Association is currently investing $430 million in more than 1,150 active projects in 57 countries spanning six continents.
“I’m honored to receive this recognition at this point in my career and grateful for the Alzheimer’s Association's support at such a critical moment in research,” said Mera Reina. “My passion lies in translational medicine, the critical link between scientific discovery and clinical application. We are hopeful that this research will contribute to the development of interventions that could benefit individuals at high risk of developing Alzheimer’s disease after brain injury.”
Mera Reina’s passion for research began during her medical studies at Del Rosario University in Colombia. She earned a Ph.D. in molecular and cellular biology at the Pontifical Catholic University of Chile, focusing on cardiovascular disease, and continued with postdoctoral training at the University of Chile. She is now expanding her expertise in the field of neuroscience through postdoctoral research at Indiana University. Her unique combination of clinical training and research experience in two critical areas of human health—cardiovascular and neurological diseases—fuels her commitment to advancing translational medicine.
Mera Reina actively participates in leadership development through various roles at Indiana University. She contributes to the biology efforts around TREM2 at the Target Enablement to Accelerate Therapy Development for Alzheimer's Disease (TREAT-AD) drug discovery center and serves as Mentorship International Chair for the Stark Postdoctoral Association (SPA), where she helps support fellow postdocs. Recent honors include Women in Neuroscience Research and Career Development Award from the Stark Neuroscience Research Institute, participation in the Association Research Fellowship to Promote Diversity Program (AARF-D) and more.
“Indiana has played a key role in many of the advances that are providing life-changing experiences for those living with dementia. We are thrilled to welcome Claudia Mera Reina to our community of researchers and look forward to her discoveries,” said Natalie Sutton, Alzheimer’s Association Greater Indiana Chapter executive. “Her work adds the exciting potential for new therapeutic strategies that could slow the progression of Alzheimer’s, inspiring hope for so many individuals and families who are affected by this terrible disease.”
Alzheimer’s Association funding has led to some of the most important research breakthroughs, including the first Alzheimer’s drug studies and recent treatment discoveries, the ability to visualize Alzheimer’s-related changes in the living brain, and advances toward blood tests. The Association also supports research that improves care for people with dementia and optimizes services for caregivers and families.
Nearly 7 million Americans are living with Alzheimer’s disease and more than 121,000 individuals are living with Alzheimer’s in Indiana alone, according to the Alzheimer’s Disease Facts and Figures, an annual report released by the Alzheimer’s Association. By 2050, the number of people with Alzheimer's is projected to increase to nearly 13 million, barring the development of medical breakthroughs to prevent, slow or stop the disease.
For more information, visit the Alzheimer’s Association at alz.org.